MAPT and early-onset autosomal dominant Alzheimer disease: To assess pathological changes in Tau, we quantified the phosphorylation of Tau in the cortex by Western blot using the AT8 antibody (p-S202 and p-T205), classically used in post-mortem biochemical staging of Alzheimer’s disease brains to indicate abnormal Tau phosphorylation [5, 17].